Cargando…
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
Several plasma-derived intermediate and high-purity concentrates containing von Willebrand factor (VWF) and factor VIII (FVIII) are currently available. The main role of these products in the management of the pediatric population is represented by the replacement therapy in patients with severe or...
Autores principales: | Castaman, Giancarlo, Linari, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936816/ https://www.ncbi.nlm.nih.gov/pubmed/27445481 http://dx.doi.org/10.2147/TCRM.S87543 |
Ejemplares similares
-
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019) -
Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013) -
Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders
por: Castaman, Giancarlo, et al.
Publicado: (2017) -
Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives
por: Castaman, Giancarlo, et al.
Publicado: (2021) -
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)